A novel measurement of allele discrimination for assessment of allele-specific silencing by RNA interference

Molecular Biology Reports

Volumn 41, Issue 11, 2014, Pages 7115-7120

  Takahashi, Masaki ^a   Hohjoh, Hirohiko ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Allele discrimination; Allele specific silencing; Novel formula; RNA interference; Small interfering RNA

Indexed keywords

SMALL INTERFERING RNA; LUCIFERASE;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; FREQUENCY DISCRIMINATION; GENE FREQUENCY; GENE SILENCING; GENETIC TRANSFECTION; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; HUMAN CELL; POINT MUTATION; PROTEIN CLEAVAGE; RNA INTERFERENCE; SEQUENCE ALIGNMENT; ALLELE; BIOLOGICAL MODEL; GENETIC ENGINEERING; GENETICS; HELA CELL LINE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROCEDURES;

ALLELES; BASE SEQUENCE; GENE SILENCING; GENETIC ENGINEERING; HELA CELLS; HUMANS; LUCIFERASES; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84917744006     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3586-7     Document Type: Article

References (22)

1. Dykxhoorn DM, Novina CD, Sharp PA (2003) Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4:457–467
2. Meister G, Tuschl T (2004) Mechanisms of gene silencing by double-stranded RNA. Nature 431:343–349
3. Seyhan AA (2011) RNAi: a potential new class of therapeutic for human genetic disease. Hum Genet 130:583–605
4. Hohjoh H (2013) Disease-causing allele-specific silencing by RNA interference. Pharmaceuticals 6:522–535
5. Hohjoh H (2010) Allele-specific silencing by RNA interference. Methods Mol Biol 623:67–79
6. Sah DW, Aronin N (2011) Oligonucleotide therapeutic approaches for Huntington disease. J Clin Invest 121:500–507
7. Rodriguez-Lebron E, Gouvion CM, Moore SA, Davidson BL, Paulson HL (2009) Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer’s disease. Mol Ther 17:1563–1573
8. Rodriguez-Lebron E, Paulson HL (2006) Allele-specific RNA interference for neurological disease. Gene Ther 13:576–581
9. Feng X, Zhao P, He Y, Zuo Z (2006) Allele-specific silencing of Alzheimer’s disease genes: the amyloid precursor protein genes with Swedish or London mutations. Gene 371:68–74
10. Miller VM, Gouvion CM, Davidson BL, Paulson HL (2004) Targeting Alzheimer’s disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res 32:661–668
11. Ohnishi Y, Tamura Y, Yoshida M, Tokunaga K, Hohjoh H (2008) Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi. PLoS ONE 3:e2248
12. Ohnishi Y, Tokunaga K, Kaneko K, Hohjoh H (2006) Assessment of allele-specific gene silencing by RNA interference with mutant and wild-type reporter alleles. J RNAi Gene Silencing 2:154–160
13. Sierant M, Paduszynska A, Kazmierczak-Baranska J, Nacmias B, Sorbi S, Bagnoli S, Sochacka E, Nawrot B (2011) Specific Silencing of L392V PSEN1 Mutant Allele by RNA Interference. J Alzheimers Dis, Int, p 809218
14. Pfister EL et al (2009) Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington’s disease patients. Curr Biol 19:774–778
15. Takahashi M, Watanabe S, Murata M, Furuya H, Kanazawa I, Wada K, Hohjoh H (2010) Tailor-made RNAi knockdown against triplet repeat disease-causing alleles. Proc Natl Acad Sci USA 107:21731–21736
16. Miller VM, Xia H, Marrs GL, Gouvion CM, Lee G, Davidson BL, Paulson HL (2003) Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci USA 100:7195–7200
17. Huang H et al (2009) Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs. Nucleic Acids Res 37:7560–7569
18. Schwarz DS et al (2006) Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet 2:e140
19. Sibley CR, Wood MJ (2011) Identification of allele-specific RNAi effectors targeting genetic forms of Parkinson’s disease. PLoS ONE 6:e26194
20. Takahashi M, Katagiri T, Furuya H, Hohjoh H (2011) Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva. Gene Ther 19(7):781–785
21. Liu J et al (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science 305:1437–1441
22. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T (2004) Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 15:185–197